Neuren Pharmaceuticals Limited’s (NURPF) Moving Averages Convergence Divergence (MACD) indicator is 0.16, suggesting Neuren Pharmaceuticals Limited is a Sell.

Neuren Pharmaceuticals Limited’s (NURPF) 20-Day exponential moving average is 8.26, while Neuren Pharmaceuticals Limited’s (NURPF) share price is $8.55, making it a Buy.

Neuren Pharmaceuticals Limited’s (NURPF) 50-Day exponential moving average is 8.36, while Neuren Pharmaceuticals Limited’s (NURPF) share price is $8.55, making it a Buy.

Advanced Chart >

Neuren Pharmaceuticals Limited (NURPF) Pivot Points

Jan 31, 2025, 07:52 PM

Classic

8.86

Fibonacci

8.86

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neuren Pharmaceuticals Limited (NURPF) Moving Averages

Jan 31, 2025, 07:52 PM

MA5

8.73Sell

8.63Sell

MA10

8.46Buy

MA20

8.03Buy

8.26Buy

MA50

8.34Buy

8.36Buy

MA100

8.69Sell

8.97Sell

MA200

10.62Sell

10.51Sell

Neuren Pharmaceuticals Limited’s (NURPF) 10-Day exponential moving average is 8.46, while Neuren Pharmaceuticals Limited’s (NURPF) share price is $8.55, making it a Buy.

Neuren Pharmaceuticals Limited’s (NURPF) 100-Day exponential moving average is 8.97, while Neuren Pharmaceuticals Limited’s (NURPF) share price is $8.55, making it a Sell.

Neuren Pharmaceuticals Limited’s (NURPF) stock price is $8.55 and Neuren Pharmaceuticals Limited’s (NURPF) 50-day simple moving average is 8.34, creating a Buy signal.

Neuren Pharmaceuticals Limited’s (NURPF) stock price is $8.55 and Neuren Pharmaceuticals Limited’s (NURPF) 100-day simple moving average is 8.69, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NURPF) stock price is $8.55 and Neuren Pharmaceuticals Limited’s (NURPF) 200-day simple moving average is 10.62, creating a Sell signal.

Neuren Pharmaceuticals Limited (NURPF) Technical Indicators

Jan 31, 2025, 07:52 PM

RSI (14)

54.16

Neutral

STOCH (9,6)

45.17

Neutral

STOCHRSI (14)

52.34

Neutral

MACD (12,26)

0.16

Sell

ADX (14)

54.06

Sell

Williams %R

-50.75

Buy

CCI (14)

72.01

Neutral

ATR (14)

1.20

Ultimate Oscillator

50.78

Neutral

ROC

15.07

Buy

Neuren Pharmaceuticals Limited’s (NURPF) Relative Strength Index (RSI) is 54.16, creating a Neutral signal.

Neuren Pharmaceuticals Limited’s (NURPF) Trend Strength Indicator (ADX) is 54.06, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NURPF) Commodity Channel Index (CCI) is 72.01, creating a Neutral signal.

Neuren Pharmaceuticals Limited’s (NURPF) Price Rate of Change (ROC) is 15.07, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is NURPF a Buy, Hold, or Sell?

Based on NURPF’s technical indicators, NURPF is a Hold.

What is NURPF’s RSI (14)?

NURPF’s RSI (14) is 54.16, which suggests NURPF is a Neutral.

What is NURPF’s MACD?

NURPF’s MACD is 0.16, which suggests NURPF is a Sell.

What is NURPF’s 5-day moving average?

NURPF’s 5-day moving average is 8.73, which suggests NURPF is a Sell.

What is NURPF’s 20-day moving average?

NURPF 20-day moving average is 8.03, which suggests NURPF is a Buy.

What is NURPF’s 50-day moving average?

NURPF’s 50-day moving average is 8.34, which suggests NURPF is a Buy.

What is NURPF’s 200-day moving average?

NURPF’s 200-day moving average is 10.62, which suggests NURPF is a Sell.

What is NURPF’s Williams % R (14)?

NURPF’s Williams % R (14) is -50.75, which suggests NURPF is a Buy.

What is NURPF’s CCI (14)?

NURPF’s CCI (14) is 72.01, which suggests NURPF is a Neutral.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing